Ad is loading...
CNWCX
Price
$76.18
Change
-$0.75 (-0.97%)
Updated
Nov 15 closing price
FNWFX
Price
$80.36
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

CNWCX vs FNWFX

Header iconCNWCX vs FNWFX Comparison
Open Charts CNWCX vs FNWFXBanner chart's image
American Funds New World 529C
Price$76.18
Change-$0.75 (-0.97%)
VolumeN/A
CapitalizationN/A
American Funds New World F3
Price$80.36
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
CNWCX vs FNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CNWCX vs. FNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNWCX is a Buy and FNWFX is a Buy.

FUNDAMENTALS
Fundamentals
CNWCX (60.9B) and FNWFX (60.9B) have equal amount of cash in the bank . FNWFX pays higher dividends than CNWCX: FNWFX (1.56) vs CNWCX (0.33). CNWCX was incepted earlier than FNWFX: CNWCX (23 years) vs FNWFX (8 years). CNWCX (32.00) and FNWFX (32.00) have comparable annual turnover. CNWCX has a lower initial minimum investment than FNWFX: CNWCX (250) vs FNWFX (1000000). FNWFX annual gain was more profitable for investors over the last year : 11.59 vs. CNWCX (10.22). FNWFX return over 5 years is better than : 17.23 vs. CNWCX (13.33).
CNWCXFNWFXCNWCX / FNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years8 years-
Gain YTD6.0417.14785%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRA250N/A-
Net Assets60.9B60.9B100%
Annual Yield % from dividends0.331.5621%
Returns for 1 year10.2211.5988%
Returns for 3 years-16.71-14.49115%
Returns for 5 years13.3317.2377%
Returns for 10 years34.62N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EDU55.900.85
+1.54%
New Oriental Education and Technology Group
HTGC18.92-0.13
-0.68%
Hercules Capital
AZ6.49-0.11
-1.67%
A2Z Cust2Mate Solutions Corp
REPL10.80-0.60
-5.26%
Replimune Group
POAI0.69-0.05
-7.23%
Predictive Oncology